IMCA renews SciSparc’s autism spectrum disorder therapy trial approval
The approval is expected to be extended following the anticipated final consent from the Israeli police department.
Neurology
MindMed doses first subject in trial of tablets for generalised anxiety disorder
AbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpoint
BioArctic doses first subject in Parkinson’s disease therapy trial
Nuvig secures $161m financing to support clinical studies for NVG-2089
Teva reports positive outcomes from episodic migraine trial in young patients
Gate Neurosciences and Pitt commence antidepressant drug trial
Sudo Biosciences begins trial of drug candidate for neuroinflammatory conditions
